Strategic Innovation Fund Awards $415M Towards New Vaccine Manufacturing Facility in Toronto
Success Stories

Strategic Innovation Fund Awards $415M Towards New Vaccine Manufacturing Facility in Toronto

Administered by the Government of Canada through the Strategic Innovation Fund (SIF), an investment of up to $415 million has been awarded to support Sanofi in building an influenza vaccine biomanufacturing facility in Toronto, Ontario.